Skip to main content
. 2025 May 27;17(6):701. doi: 10.3390/pharmaceutics17060701
AI Artificial Intelligence
API Active Pharmaceutical Ingredient
AUC Area Under the Curve
BBD Box–Behnken Design
CCD Central Composite Design
CMA Critical Material Attributes
Cmax Maximum Concentration
CPP Critical Process Parameters
Co-S Co-Surfactant
DL Drug Loading
DoE Design of Experiment
DR Drug Release
ET Emulsification Time
FMEA Failure Mode and Effects Analysis
GS Globule Size
ICH International Council for Harmonisation
MD Molecular Dynamic
ML Machine Learning
PBPK Physiologically Based Pharmacokinetic
PDI Polydispersity Index
QbD Quality by Design
QTPP Quality Target Product Profile
RAM Risk Assessment Matrix
REM Risk Estimation Matrix
RSM Response Surface Methodology
SLD Simplex Lattice Design
Smix Surfactant and Co-Surfactant Mixture
SNEDDS Self-Nanoemulsifying Drug Delivery System
ZP Zeta Potential